Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis

Area of Science:

• Neuroimmunology
• Inflammatory and Demyelinating Diseases
• Vascular Biology

Background:

• Multiple sclerosis (MS) is a central nervous system inflammatory demyelinating disorder.
• T helper 1 (Th1) and T helper 17 (Th17) cells are key players in MS pathogenesis.
• Elevated endothelin-1 (ET-1) levels are observed in MS patients' sera.

Purpose of the Study:

• To investigate the role of ET-1 in experimental allergic encephalomyelitis (EAE), an animal model for MS.
• To determine how ET-1 overexpression affects EAE severity and associated inflammatory responses.

Main Methods:

• EAE was induced in transgenic mice overexpressing ET-1 (endothelial and astrocytic) and non-transgenic controls.
• Evaluated EAE scores, spinal cord histology, and serum/splenocyte cytokine levels (IL-6, IL-17A, IFN-γ, TNF-α, IL-4).

Main Results:

• ET-1 transgenic mice exhibited significantly more severe EAE compared to non-transgenic mice.
• Increased spinal cord inflammation and demyelination were observed in ET-1 overexpressing mice.
• Elevated serum and splenocyte production of pro-inflammatory cytokines (IL-6, IL-17A, IFN-γ, TNF-α) were noted in ET-1 transgenic mice.

Conclusions:

• Overexpression of ET-1, whether in endothelial or astrocytic cells, worsens EAE.
• Increased ET-1 leads to heightened Th1 and Th17 pro-inflammatory cytokine production in splenic lymphocytes.